Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | EGRX |
---|---|---|
10:18 ET | 767 | 0.95 |
10:27 ET | 102 | 0.6501 |
01:27 ET | 1226 | 0.7501 |
01:38 ET | 125 | 0.7501 |
01:51 ET | 358 | 0.80025 |
01:56 ET | 1000 | 0.80025 |
01:58 ET | 201 | 0.7505 |
02:41 ET | 6035 | 0.95 |
02:52 ET | 283 | 0.95 |
03:10 ET | 424 | 0.95 |
03:12 ET | 450 | 0.95 |
03:28 ET | 100 | 0.95 |
03:46 ET | 300 | 0.95 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Eagle Pharmaceuticals Inc | 11.7M | 1.0x | -4.75% |
Shengtai Pharmaceutical Inc | 10.0 | 0.0x | --- |
Medicine Man Technologies Inc | 6.2M | --- | --- |
Lotus Pharmaceuticals Inc | 8.9M | 0.0x | +42.39% |
Cumberland Pharmaceuticals Inc | 15.2M | -1.4x | --- |
Aoxing Pharmaceutical Company Inc | 4.9M | -0.8x | --- |
Eagle Pharmaceuticals, Inc. is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial capabilities. The Company is focused on developing medicines that result in improvements in patients' lives. The Company's commercialized products include vasopressin, PEMFEXY, RYANODEX, BENDEKA, BELRAPZO, TREAKISYM (Japan), and BYFAVO and BARHEMSYS through its wholly owned subsidiary Acacia Pharma Inc. Its oncology and central nervous system (CNS)/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. The Company also has a research and development facility in Cambridge, Massachusetts. The Company has office space in Palm Beach Gardens, Florida and Indianapolis, Indiana. The Company’s subsidiaries include Eagle Biologics, Inc., Eagle Research Lab Limited, Acacia Pharma Group plc, Acacia Pharma Limited and Acacia Pharma Inc.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $11.7M |
---|---|
Revenue (TTM) | $257.6M |
Shares Outstanding | 13.0M |
Eagle Pharmaceuticals Inc does not pay a dividend. | |
Beta | 0.71 |
EPS | $0.91 |
Book Value | $17.94 |
P/E Ratio | 1.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | 0.4x |
Operating Margin | 13.98% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.